Sorrento Therapeutics Inc (SRNE)

[KCAC]

Here are the 3 largest Biotech IPO's so far this year. I think NK has the possibility of cracking this top 3 list, does anyone know if Dr. S-S's recent crosstrade counts towards the IPO process and would be in addition to money raised in the IPO which I think will be substantially oversubscribed?



#3. Galapagos

Amount: $316.7 million in gross proceeds (approximately €278.7 million)21

Date: May 19

Shares/ Price per share: 7,532,499 shares at $42.0522

Symbol/Market: GLPG on NASDAQ Global Select Market, as well as on Euronext Amsterdam and Euronext Brussels



#2. Axovant Sciences

Amount: $362 million in gross proceeds prior to deducting underwriting discounts and commissions and estimated offering expenses payable by company23

Date: June 16

Shares/Price per share: 24.15 million shares at $1524

Symbol/Market: AXON on New York Stock Exchange



#1. 3SBio

Amount: $534 million in net proceeds after deducting underwriting fees and estimated expenses in connection with the offering

Date: June 24

Shares/Price per share: 853,052,440 shares at HK$9.10 ($1.17)25

Symbol/Market: 1530 on Hong Kong Exchange